At a glance
ClinicalIndex Comparison RecordN/ACompleted· 52 enrolled
Drug / intervention
AcrySof IQ PanOptix Multifocal IOLdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Investigation of the Visual Outcomes and Safety After Bilateral Implantation of a Trifocal Presbyopia Correcting IOL in a Korean Population
In Brief
A clinical study evaluating AcrySof IQ PanOptix Multifocal IOL for Cataract and Presbyopia. Completed, enrolled 52 participants across 4 sites.
Detailed Summary
The purpose of this study is to confirm the effectiveness of the investigational lens in a Korean population, especially for visual performance, quality of vision, and subject satisfaction with the visual outcome, as well as the safety of the lens. This trial will be conducted in Korea.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCataract, Presbyopia
CountriesSouth Korea
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedAug 2017
Enrollment StartJan 2018
Primary CompletionNov 2018
TodayJul 2026
First PostedAug 31, 2017
Enrollment StartJan 9, 2018
Primary CompletionNov 30, 2018
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 8.8 years ago
Interventions
AcrySof IQ PanOptix Multifocal IOLdevice
AcrySof IQ PanOptix Multifocal IOL Model TFNT00 for near, intermediate, and distance vision intended for long-term use over the lifetime of the cataract subject